Literature DB >> 25056870

Of women seeking assistance for intimate partner violence, those who report victimisation during pregnancy are at higher risk of further victimisation.

Julianne C Flanagan1.   

Abstract

Implications for practice and research: The benefits of integrating regular intimate partner violence (IPV) screening procedures for pregnant women in clinical settings outweigh the cost of minimal time spent conducting assessments. Healthcare providers must be trained to conduct IPV assessments and provide treatment referrals. Future studies should use larger samples and compare shelter populations with general prenatal care.

Entities:  

Mesh:

Year:  2014        PMID: 25056870      PMCID: PMC4377642          DOI: 10.1136/eb-2014-101869

Source DB:  PubMed          Journal:  Evid Based Nurs        ISSN: 1367-6539


  5 in total

1.  Pregnancy and intimate partner violence: risk factors, severity, and health effects.

Authors:  Douglas A Brownridge; Tamara L Taillieu; Kimberly A Tyler; Agnes Tiwari; Susy C Santos
Journal:  Violence Against Women       Date:  2011-07

2.  Women's intimate partner violence perpetration during pregnancy and postpartum.

Authors:  Julianne C Hellmuth; Kristina Coop Gordon; Gregory L Stuart; Todd M Moore
Journal:  Matern Child Health J       Date:  2013-10

3.  Risk factors for intimate partner violence during pregnancy and postpartum.

Authors:  Julianne C Hellmuth; Kristina Coop Gordon; Gregory L Stuart; Todd M Moore
Journal:  Arch Womens Ment Health       Date:  2012-09-30       Impact factor: 3.633

4.  Commission versus receipt of violence during pregnancy: associations with substance abuse variables.

Authors:  Golfo K Tzilos; Emily R Grekin; Jessica R Beatty; Sara K Chase; Steven J Ondersma
Journal:  J Interpers Violence       Date:  2009-12-04

5.  Screening for intimate partner violence in health care settings: a randomized trial.

Authors:  Harriet L MacMillan; C Nadine Wathen; Ellen Jamieson; Michael H Boyle; Harry S Shannon; Marilyn Ford-Gilboe; Andrew Worster; Barbara Lent; Jeffrey H Coben; Jacquelyn C Campbell; Louise-Anne McNutt
Journal:  JAMA       Date:  2009-08-05       Impact factor: 56.272

  5 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.